There is no current role for molecular phenotyping in metastatic castrate-resistant prostate cancer.
There is no current role for molecular phenotyping in metastatic castrate-resistant prostate cancer.
Clin Adv Hematol Oncol. 2015 Sep;13(9):580-5
Authors: Vogelzang NJ
PMID: 26452189 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research